{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4918"}, "official-title": {"#tail": "\n\t", "#text": "To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved\n\t\t\t for marketing in the European Union."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140619", "#text": "June 19, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Stivers", "@name-id": "S001187"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Ryan of Ohio", "@name-id": "R000577"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HC166D54D77DC41DF899BB1B004A02781", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Speeding Access to Already Approved Pharmaceuticals Act of 2014", "@value": "Speeding Access to Already Approved Pharmaceuticals Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HD54EAD64F9C94DFE9B90AB07AF95AFC1"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Expedited review of EU-approved pharmaceuticals"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the\n\t\t\t end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 506 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:506"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 356", "@value": "usc/21/356"}, "@parsable-cite": "usc/21/356", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "EU-Approved pharmaceuticals"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall, at the request of the sponsor of the\n\t\t\t pharmaceutical, facilitate the development and expedite the review of such\n\t\t\t new pharmaceutical under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " or ", "@entity-type": "act", "#text": "515 of this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:515"}, {"#tail": ", as appropriate.", "@entity-type": "act", "#text": "section 351 of\n\t\t\t the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "Beginning not later than 90 days after a new pharmaceutical is approved for marketing in the\n\t\t\t European Union, the "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Expedited review"}, "#text": "\n              ", "@id": "H98B2D7F28B774B6192F4CAC77D6F2B89"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "term": {"#tail": " means a drug (including a biological product) or a device.", "#text": "pharmaceutical"}, "#text": "In this subsection, the term "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Definition"}, "#text": "\n              ", "@id": "HB314F8B2F06240D8AE1C833DBD73E424"}], "#text": "\n            ", "@id": "H1B29FA3875174928A7134909DE2A4B71"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HD4C5911A39CC43BF9A97EACFB6B14297"}, "#text": "\n        ", "@id": "HF3494B70ABC545F4BEDB040711CBB686"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t (e) (relating to construction) of such section 506", "@value": "Federal Food, Drug, and Cosmetic Act/s:506/ss:e"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is hereby moved so as to follow ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subsection (f) (relating to awareness efforts) of section 506 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:506/ss:f"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 356", "@value": "usc/21/356"}, "@parsable-cite": "usc/21/356", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Technical correction"}, "#text": "\n        ", "@id": "H4C9C7721F3744C6DA233B39DAA4F6C4C"}], "#text": "\n      ", "@id": "HDF462473014A48958A420C96024878A9"}], "#text": "\n\t\t", "@id": "H3CB0F1F30977424DB01A9A18FCEAD3A9"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-06-19"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4918 IH: Speeding Access to Already Approved Pharmaceuticals Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}